Cost-Conscious ASCs Seek Sourcing Strategies

Vizient launched a first-of-its-kind sourcing program that targets ASCs. The initiative serves as an example of the evolving opportunities the ASC market will open for industry in the years ahead.

How Will Tariffs and FDA Firings Impact Orthopedic Companies?

The federal government’s sweeping changes have created complexity and uncertainty for the medical device industry.

AAOS Recap: Robotics, Orthobiologics and M&A Activity Gain Attention

Industry and surgeons attending the AAOS Annual Meeting spoke with optimism about market growth and new technology.

Policy and Regulatory Changes to Watch in 2025

AI, biocompatibility, reimbursement, tariffs and taxes are a handful of the issues MDMA is closely watching and advocating for on behalf of orthopedic companies.